Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
3,545
Total Claims
$1.2M
Drug Cost
595
Beneficiaries
$1,943
Cost/Patient
Risk Score Breakdown 18/100
Score components are additive. Read full methodology
Peer Comparison vs. 13,194 Neurology providers
+77%
Opioid rate vs peers
2.3% vs 1.3% avg
-52%
Cost per patient vs peers
$1,943 vs $4,034 avg
+2%
Brand preference vs peers
9.6% vs 9.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
2.3%
Opioid Rate
82
Opioid Claims
$1,374
Opioid Cost
26.8%
Long-Acting Rate
Brand vs Generic
Brand: 340 claims · $952K
Generic: 3,187 claims · $203K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Interferon Beta-1a/Albumin | 11 | $118K |
| Interferon Beta-1b | 12 | $107K |
| Teriflunomide | 11 | $102K |
| Erenumab-Aooe | 81 | $68K |
| Immun Glob G(Igg)/Gly/Iga Ov50 | 12 | $64K |
| Rotigotine | 51 | $49K |
| Teriflunomide | 11 | $27K |
| Carbidopa/Levodopa | 292 | $19K |
| Dimethyl Fumarate | 13 | $19K |
| Rivastigmine | 50 | $14K |
| Solriamfetol Hcl | 14 | $11K |
| Gabapentin | 346 | $11K |
| Dalfampridine | 19 | $9,839 |
| Carbamazepine | 37 | $8,858 |
| Levetiracetam | 217 | $8,069 |
Prescribing Profile
59
Unique Drugs
18.0
Anomaly Score
Patient Profile
72
Avg Age
55%
Female
1.55
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About